| abstract |
The present invention relates to a novel method for preparing the compound of the formula (IA), the compound of formula (IA) is the effective and specific antagonist of the corticotrophin releasing factor (CRF) acceptor, the method begins from the intermediate compound of the formula (I) and through the coupling reaction catalyzed by the copper, wherein X is halogen; and other substituent groups are defined in the instruction book. |